Published in
Wiley, British Journal of Pharmacology, 3(171), p. 723-734, 2014
DOI: 10.1111/bph.12490
Links
- ORCID
- Wiley | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration: Exendin-4 reduces liver inflammation
Journal article published in 2014 by
Y. Wang,
S. J. L. van der Tuin,
S. C. A. de Jager,
E. T. Parlevliet,
J. J. Geerling,
S. J. L. Tuin,
H. Zhang,
V. Bieghs,
A. H. M. Jawad,
R. Shiri-Sverdlov 
,
I. Bot,
S. C. A. Jager,
L. M. Havekes,
J. A. Romijn,
K. Willems van Dijk
and other authors.
,
I. Bot,
S. C. A. Jager,
L. M. Havekes,
J. A. Romijn,
K. Willems van Dijk
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 